Home / Lose weight / Medication

Weight Loss Medication

An Overview of the Medications

This page has been reviewed by
Dr. Nicolette Lammers.

Medication for Weight Loss

Wegovy

Wegovy contains semaglutide, a GLP-1 receptor agonist that affects hunger and satiety. It is used for medically supervised weight reduction in patients with obesity or in patients with overweight and weight-related comorbidities.
Price This medication is part of the comprehensive “Weight Loss with Injections” program.

You can find more details about pricing on our pricing page.
Administration Weekly injection pen
Active ingredient Semaglutide
Target group Obesity: BMI ≥ 30 or overweight: BMI ≥ 27 with a weight-related condition
Mode of action The medication mimics the natural GLP-1 hormone. It helps regulate appetite, increases satiety, and supports blood sugar metabolism.
Side effects Information about all possible side effects can be found in the  package insert  or  on our page about Wegovy side effects .

Mounjaro

Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist that affects hunger and satiety. It is used to treat type 2 diabetes and for medically supervised weight reduction in patients with obesity or overweight and weight-related comorbidities.
Price This medication is part of the comprehensive “Weight Loss with Injections” program.

You can find more details about pricing on our pricing page.
Administration Weekly injection pen
Active ingredient Tirzepatide
Target group Type 2 diabetes and obesity: BMI ≥ 30 or overweight: BMI ≥ 27 with a weight-related condition
Mode of action Tirzepatide activates GIP and GLP-1 receptors. It can support insulin release, reduce glucagon secretion, slow gastric emptying, and decrease appetite.
Side effects Information about all possible side effects can be found in the  package insert  or  on our page about Mounjaro side effects .

Saxenda

Saxenda contains liraglutide, a GLP-1 receptor agonist that affects hunger and satiety. It is used for medically supervised weight reduction in patients with obesity or in patients with overweight and weight-related comorbidities.
Price This medication is part of the comprehensive “Weight Loss with Injections” program.

You can find more details about pricing on our pricing page.
Administration Daily injection pen
Active ingredient Liraglutide
Target group Obesity: BMI ≥ 30 or overweight: BMI ≥ 27 with a weight-related condition
Mode of action The medication mimics the natural GLP-1 hormone. It helps regulate appetite, increases satiety, and supports blood sugar metabolism.
Side effects Information about all possible side effects can be found in the  package insert  or  on our page about Saxenda side effects .

Ozempic

Ozempic contains semaglutide, a GLP-1 receptor agonist that supports blood sugar regulation and may affect satiety. It is approved for type 2 diabetes; its use in the context of weight reduction must be assessed individually by a doctor.
Price This medication is part of the comprehensive “Weight Loss with Injections” program.

You can find more details about pricing on our pricing page.
Administration Weekly injection pen
Active ingredient Semaglutide
Target group Type 2 diabetes
Mode of action The medication mimics the natural GLP-1 hormone. It helps regulate appetite, increases satiety, and supports blood sugar metabolism.
Side effects Information about all possible side effects can be found in the  package insert  or  on our page about Ozempic side effects .

Weight Loss With Medical Supervision

If there is a medical indication, the following prescription weight-loss medications may be considered. Your doctor will discuss suitable treatment options with you, either online via video consultation or at one of our locations in:

If medication-based support is medically appropriate, a prescription can be issued and the medication can be delivered through The Body Clinic’s partner pharmacy.
ihre behandlung vor ort oder online bei the body clinic
Note: Some weight-loss medications are currently only available to a limited extent or are not available at all.

Additional Medications

Below you will find an overview of medications that we currently do not offer, or offer only upon request, as part of our medical weight loss program. These medications are also prescription-only, which means they are not available over the counter and may only be prescribed after an individual medical consultation. During this consultation, the doctor assesses whether the medication is appropriate and safe for your situation.

Rybelsus

Rybelsus contains semaglutide and is used to treat type 2 diabetes. The medication can support blood sugar regulation and affect satiety. At The Body Clinic, Rybelsus is currently available only upon request.
Price

Rybelsus is a prescription medication containing semaglutide in tablet form. Treatment with Rybelsus is not currently offered as a regular option at The Body Clinic, but may be requested for individual medical assessment.

You can find a general overview of the costs of our medically supervised weight loss program on our pricing page.
Administration Tablet, once daily
Active ingredient Semaglutide
Target group Type 2 diabetes
Mode of action The medication mimics the natural GLP-1 hormone. It helps regulate appetite and increases satiety.
Side effects Information about all possible side effects can be found in the  package insert  or  on our page about Rybelsus side effects .

Mysimba

Mysimba is approved in the EU. However, the medication is not currently available in Germany and is not offered at The Body Clinic at this time.

Price

Mysimba is currently not available in Germany and is not currently offered by The Body Clinic.

You can find a general overview of the costs of our medically supervised weight loss program on our pricing page.
Administration Tablet, twice daily
Active ingredient Naltrexone / Bupropion
Target group Obesity: BMI ≥ 30 or overweight: BMI ≥ 27 with a weight-related condition
Mode of action The medication affects central signaling pathways involved in appetite and eating behavior and may help reduce food cravings and impulsive eating.
Side effects Information about all possible side effects can be found in the  package insert  or  on our page about Mysimba side effects .

Retatrutide

Retatrutide is a new drug candidate for weight reduction that is currently being investigated in clinical trials. The medication is not currently approved in Germany or the EU and therefore cannot currently be offered by The Body Clinic.
Price

Retatrutide is not currently approved and is not available at The Body Clinic. For this reason, no prices or treatment costs for retatrutide can currently be provided.

You can find a general overview of the costs of our medically supervised weight loss program on our pricing page.
Administration Subcutaneous injection, once weekly
Active ingredient Retatrutide
Mode of action Retatrutide activates three hormone receptors and may therefore influence appetite, satiety, metabolism, and energy expenditure.

Orforglipron

Orforglipron is a new drug candidate in tablet form that is currently being investigated for the treatment of obesity and type 2 diabetes. The medication is not currently approved in Germany or the EU and therefore cannot currently be offered by The Body Clinic.
Price

Orforglipron is not currently approved in Germany and is not available at The Body Clinic. For this reason, no prices or treatment costs for orforglipron can currently be provided.

You can find a general overview of the costs of our medically supervised weight loss program on our pricing page.
Administration Tablet, once daily
Active ingredient Orforglipron
Mode of action Orforglipron activates GLP-1 receptors and may therefore influence appetite, satiety, blood sugar regulation, and body weight.

Wegovy Pill

The Wegovy pill contains semaglutide, a GLP-1 receptor agonist used for medical weight reduction. The oral dosage form has been recommended by the EMA for an extension of the existing Wegovy approval, but it is not yet routinely available in Germany. At The Body Clinic, the Wegovy pill cannot currently be offered.

Price

Because the Wegovy pill is not yet routinely available in Germany, no prices or treatment costs can currently be provided for this dosage form.

You can find a general overview of the costs of our medically supervised weight loss program on our pricing page.
Administration Tablet, once daily
Active Ingredient Semaglutide
Target Group Adults with obesity or overweight and at least one weight-related comorbidity
Mode of Action Semaglutide activates GLP-1 receptors and may therefore influence hunger, appetite, satiety, and blood sugar regulation.

Your Journey to Sustainable Weight Loss Starts Here

mounjaro programm the body clinic landingpage mounjaro

Why Medications Can Help With Weight Loss

Weight-loss medications can be a useful form of support when overweight or obesity requires medical treatment and previous weight-loss attempts have not been sufficiently successful. Many patients have tried several times to lose weight through diet, exercise, or structured eating plans, but have not been able to maintain the weight loss long term.

In these cases, medication-based treatment can help address biological factors such as hunger, appetite, and satiety. It is important to understand that weight-loss medications are not a stand-alone solution. They are always used as part of a medically supervised treatment plan.

How Weight-Loss Medications Work

Modern weight-loss medications act on the body’s own signaling pathways that influence hunger, appetite, satiety, and in some cases metabolism. Important active ingredients in weight-loss medications include semaglutide, liraglutide, and tirzepatide.

GLP-1-based active ingredients can help satiety occur earlier and may make it easier to control meals. Tirzepatide also acts on the GIP and GLP-1 receptors. Some active ingredients also support blood sugar regulation, which can be especially relevant for certain weight-related conditions.

abnehmmedikamente wirkstoffe wirkung medizinische gewichtsreduktion the body clinic.webp

Who May Be Eligible for Medication

Whether a weight-loss medication is suitable always depends on the individual medical situation. Important factors include BMI, the extent and duration of excess weight, previous weight-loss attempts, pre-existing conditions, current medications, and possible contraindications.

Several medications approved in the EU for weight management may be considered for patients with obesity or for patients with overweight and at least one weight-related comorbidity. These may include type 2 diabetes, high blood pressure, abnormal blood lipid levels, or sleep apnea. The final decision should always be made by a doctor.

Why Medical Supervision Matters

Medical weight loss means more than receiving a prescription. Before treatment begins, it should be assessed whether medication-based treatment is medically appropriate and safe. This includes a medical history, an assessment of possible risks, selection of the appropriate medication, and clear guidance on administration, dosage, and potential side effects.

Regular follow-up during treatment is also important. This makes it possible to assess whether the medication is well tolerated, whether the dose should be adjusted, and whether nutrition, physical activity, and everyday routines realistically support the treatment goal.

FAQs About Weight-Loss Medications

Well-known medications for medical weight reduction include Wegovy, Mounjaro, and Saxenda. They are administered as injections and contain active ingredients that can influence hunger, appetite, and satiety. Other medications, such as Ozempic or Rybelsus, are primarily approved for the treatment of type 2 diabetes. Whether a medication may be considered in the context of weight reduction must always be assessed individually by a doctor.

At The Body Clinic, the focus is on medically supervised treatment options with approved medications for weight reduction. Some of the medications mentioned on this page are currently not regularly available: Rybelsus is available only upon request, Mysimba is currently not available in Germany, retatrutide is still being investigated in clinical trials, and orforglipron is not currently approved.

Well-known weight-loss injections include Wegovy with semaglutide, Mounjaro with tirzepatide, and Saxenda with liraglutide. They differ in terms of active ingredient, administration, dosage, approval status, and individual suitability. Which weight-loss injection is suitable should always be decided by a doctor.

Yes, there are also medications in tablet form. Rybelsus contains semaglutide, but it is approved for the treatment of type 2 diabetes and is currently available at The Body Clinic only upon request. Mysimba is another well-known medication in tablet form, but it is currently not available in Germany. Orforglipron is a new oral drug candidate, but it is not currently approved.

Important active ingredients in modern weight-loss medications include semaglutide, tirzepatide, and liraglutide. They act on different signaling pathways involved in hunger, appetite, satiety, and, in some cases, blood sugar regulation. You can find an overview on our page about active ingredients in weight-loss medications.

Weight-loss medications are generally considered for patients with obesity or for patients with overweight and weight-related comorbidities. Important factors include BMI, pre-existing conditions, previous weight-loss attempts, current medications, and possible contraindications. Eligibility should always be assessed individually as part of a medical consultation.

No. The medications described on this page are prescription-only and should not be used without medical assessment. Before starting treatment, suitability, dosage, possible side effects, and individual risks must be evaluated by a doctor.

There is no general answer to this question. The appropriate treatment depends on the individual medical situation, treatment goal, possible comorbidities, previous weight-loss attempts, and tolerability. At The Body Clinic, we first assess whether medication-based support is medically appropriate and which medication may be considered.

Possible side effects depend on the specific medication and active ingredient. They often affect the gastrointestinal system and may include nausea, a feeling of fullness, diarrhea, or constipation. It is important to discuss side effects with a doctor early and not to change the dosage on your own.

The cost depends on the medication, dosage, treatment duration, and individual treatment plan. You can find a general overview of the costs of our medically supervised weight loss program on our pricing page.

Doctors

Real doctors, personalized support: These experienced, licensed physicians work with you in personal consultations to develop the best therapy for long-term, sustainable weight loss.

Scroll to Top